Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin | Zendy

Jeff S. Healey | Zendy; John W. Eikelboom | Zendy; James D. Douketis | Zendy; Lars Wallentin | Zendy; Jonas Oldgren | Zendy; Sean Yang | Zendy; Ellison Themeles | Zendy; Hein Heidbüchel | Zendy; Álvaro Avezum | Zendy; Paul Reilly | Zendy; Stuart J. Connolly | Zendy; Salim Yusuf | Zendy; Michael D. Ezekowitz | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin

Author(s) -

Jeff S. Healey,

John W. Eikelboom,

James D. Douketis,

Lars Wallentin,

Jonas Oldgren,

Sean Yang,

Ellison Themeles,

Hein Heidbüchel,

Álvaro Avezum,

Paul Reilly,

Stuart J. Connolly,

Salim Yusuf,

Michael D. Ezekowitz

Publication year - 2012

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.111.090464

Subject(s) - dabigatran , medicine , warfarin , atrial fibrillation , rivaroxaban , anesthesia , stroke (engine) , apixaban , surgery , mechanical engineering , engineering

Dabigatran reduces ischemic stroke in comparison with warfarin; however, given the lack of antidote, there is concern that it might increase bleeding when surgery or invasive procedures are required.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research